Gene Expression Market Size, Share and Forecast Trends - Growth Analysis and Outlook Report (2026-2035)

The gene expression market was valued at USD 14.68 Billion in 2025. It is poised to grow at a CAGR of 10.40% during the forecast period of 2026-2035, and reach USD 39.48 Billion by 2035. Rising demand for precision medicine and increased adoption of advanced gene expression technologies are driving market growth, supported by expanding research activities, clinical applications, and continuous innovations in genomic analysis tools.

Key Market Trends and Insights

• By product and services, consumables accounted for over 48% of the market share during the historical period.
• By end user, pharmaceutical and biotechnology companies held more than 35% of the revenue share in the historical period.
• Based on region, North America dominated the market with a share exceeding 42% during the historical period.

Market Size and Forecast

• Market Size (2025): USD 14.68 Billion
• Projected Market Size (2035): USD 39.48 Billion
• CAGR (2026-2035): 10.40%

Gene Expression Market Overview

The market is expanding rapidly due to advancements in molecular biology and precision medicine. Technologies such as RNA sequencing are enabling deeper insights into cellular functions, driving demand across research and clinical applications. Increasing focus on personalized therapies, biomarker discovery, and disease diagnostics continues to fuel innovation, while investments in biotechnology and genomics research further support sustained market growth globally. The market reached a value of approximately USD 14.68 Billion in 2025.

Gene Expression Market Growth Drivers

Advancements in RNA Sequencing Accelerating the Market Demand

Increasing demand for precision medicine and rising investments in genomics research are key drivers propelling the gene expression market. For instance, in October 2025, Plasmidsaurus introduced an ultrafast RNA sequencing service that significantly reduces turnaround time while improving affordability and accessibility for researchers. This development enhances workflows involving transcriptomics, qPCR validation, and differential expression studies. During the forecast period, such innovations are expected to accelerate adoption, streamline research processes, and expand market penetration across clinical and academic applications.

Gene Expression Market Trends

Key trends shaping the market include rising adoption of single-cell RNA-seq, AI-driven analysis, and precision medicine advancements.

Increasing AI-Driven Genomics Innovations to Boost the Market Value

Rising adoption of artificial intelligence in genomics and increasing investments in large-scale biological datasets are key factors influencing market trends. In January 2026, Illumina introduced the Billion Cell Atlas, a comprehensive dataset mapping gene activity across vast cell populations, strengthening applications in epigenomics alongside RNA sequencing and microarray technologies. In the forecast period, such initiatives will drive data-driven innovation, improving scalability and accelerating precision medicine advancements.

Gene Expression Market Segmentation

Market Breakup by Products and Services

• Consumables
• Instruments
• Services

Market Breakup by Technology

• Polymerase Chain Reaction
• Next Generation Sequencing
• DNA Microarray
• Others

Market Breakup by Application

• Disease Diagnosis
• Drug Discovery
• Drug Development
• Others

Market Breakup by End User

• Pharmaceutical and Biotechnology Companies
• Academic and Research Institute
• Diagnostic and Clinical Laboratories
• Others

Market Breakup by Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East and Africa

Gene Expression Market Share

Consumables Expected to Lead the Market Share by Product and Services

Consumables accounted for over 48% of the gene expression market share in the historical period, driven by their recurring usage in laboratory workflows and high demand across research and clinical settings. Products supporting transcriptomics studies, including reagents and kits, contribute significantly to this dominance, as they are essential for accurate and scalable gene expression profiling across diverse applications.

Gene Expression Market Analysis by Region

North America is expected to dominate the market with a share exceeding 42% in the historical period, supported by strong research infrastructure and funding. The region’s leadership is reinforced by widespread adoption of advanced technologies such as RNA sequencing, enabling precise gene expression analysis and accelerating innovation in diagnostics, drug discovery, and personalized medicine across pharmaceutical and biotechnology sectors.

Leading Players in the Gene Expression Market

The key features of the market report comprise patent analysis, funding and investment analysis, and strategic initiatives by the leading players. The major companies in the market are as follows:

Illumina Inc.

Illumina Inc., headquartered in San Diego, California, and founded in 1998, is a global leader in genomic technologies. Its portfolio includes sequencing platforms, reagents, and gene expression solutions widely used in research and clinical settings, particularly enabling advanced transcriptomics applications.

Thermo Fisher Scientific

Thermo Fisher Scientific, headquartered in Waltham, Massachusetts, and established in 2006, provides comprehensive life sciences solutions. Its gene expression portfolio includes PCR systems, reagents, and sequencing technologies supporting advanced qPCR workflows. The company continues expanding molecular diagnostics capabilities through strategic product innovations and partnerships to strengthen precision medicine and research applications globally.

Promega Corporation

Promega Corporation, founded in 1978 and headquartered in Madison, Wisconsin, develops reagents, assays, and instrumentation for life sciences research. Its gene expression portfolio includes luciferase assays, RNA analysis tools, and systems supporting gene regulation studies. The company focuses on enabling cellular and molecular research through innovative solutions tailored to academic, clinical, and pharmaceutical applications.

Revvity Inc.

Revvity Inc., formerly PerkinElmer, Inc., headquartered in Waltham, Massachusetts, and established in 1937, provides diagnostic and life sciences solutions. Its gene expression offerings include reagents, detection systems, and imaging platforms supporting epigenomics and biomarker discovery. The company emphasizes precision health by advancing technologies for disease detection, translational research, and drug development across global markets.

Other key players in the market are Agilent Technologies Inc., Oxford Nanopore Technologies Inc., F. Hoffmann La Roche Ltd., PacBio, Bio-Rad Laboratories Inc., Danaher Life Sciences, Takara Bio Inc., and QIAGEN.

Key Questions Answered in the Gene Expression Market Report

• What was the gene expression market value in 2025?
• What is the gene expression market forecast outlook for 2026-2035?
• What major factors aid the demand for gene expression market?
• How has the market performed so far, and how is it anticipated to perform in the coming years?
• What are the market’s major drivers, opportunities, and restraints?
• What are the major gene expression market trends?
• Which product and services are expected to dominate the market segment?
• Which technology is expected to dominate the market segment?
• Which application is expected to dominate the market segment?
• Which end user is expected to dominate the market segment?
• Who are the key players in the gene expression market?
• What are the current unmet needs and challenges in the market?
• How are partnerships, collaborations, mergers, and acquisitions among the key market players shaping the market dynamics?